Ginkgo Biloba Memory Randomized Trial Evidence Table

Structured evidence table for Ginkgo Biloba Memory Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Ginkgo Biloba Memory Randomized TrialThe second study confirmed the GBP benefits on mood states and a visually consistent downward trend in reaction times across all four cognitive performance tests at both GBP dosages, suggesting improved processing speed in response to various stimuli.2Hawkins K (2026)Health Benefits of a Standardized <i>Ginkgo biloba</i> Extract Associated With Phosphatidylserine in Alleviating Mental Stress and Cognitive Performance: Results From Two Exploratory Randomized Trials.
Ginkgo Biloba Memory Randomized TrialMental health is threatened every day by the stressors of life: frenetic work rhythms, stressful conditions can generate anxiety, depression, cognition, and sleep problems.2Hawkins K (2026)Health Benefits of a Standardized <i>Ginkgo biloba</i> Extract Associated With Phosphatidylserine in Alleviating Mental Stress and Cognitive Performance: Results From Two Exploratory Randomized Trials.
Ginkgo Biloba Memory Randomized TrialAmong natural products with properties to support mental health, Gingko biloba extract with phosphatidylserine (GBP) was exploited with the aim of evaluating its benefits in cognitive function, mood regulation, and overall quality of life.2Hawkins K (2026)Health Benefits of a Standardized <i>Ginkgo biloba</i> Extract Associated With Phosphatidylserine in Alleviating Mental Stress and Cognitive Performance: Results From Two Exploratory Randomized Trials.
Ginkgo Biloba Memory Randomized TrialIn addition, an overview of systematic reviews synthesized the broader EGb 761 evidence base across indications and highlighted that conclusions require caution given the methodological limitations of many reviews [].3Yang YoungSoon (2026)Ginkgo Biloba for Alzheimer’s Disease: From Mixed Dementia Trials to Biomarker-Confirmed Mild Cognitive Impairment—What Have We Learned over Two Decades, and Is There Finally a Bit of Hope?
Ginkgo Biloba Memory Randomized TrialReal-world observational analyses have also reported associations between prescriptions of Ginkgo leaf extract and reduced risk of dementia severity progression, albeit with the inherent limitations of non-randomized designs [].3Yang YoungSoon (2026)Ginkgo Biloba for Alzheimer’s Disease: From Mixed Dementia Trials to Biomarker-Confirmed Mild Cognitive Impairment—What Have We Learned over Two Decades, and Is There Finally a Bit of Hope?
Ginkgo Biloba Memory Randomized TrialAccordingly, this review revisits the historical evidence base with explicit attention to heterogeneity and methodological design, and then examines biomarker-confirmed AD-spectrum studies as a potential pivot point.3Yang YoungSoon (2026)Ginkgo Biloba for Alzheimer’s Disease: From Mixed Dementia Trials to Biomarker-Confirmed Mild Cognitive Impairment—What Have We Learned over Two Decades, and Is There Finally a Bit of Hope?
Ginkgo Biloba Memory Randomized Trial1 2 Alzheimer’s disease (AD) remains the most common cause of dementia and continues to impose a major burden on patients, caregivers, and healthcare systems [].3Yang YoungSoon (2026)Ginkgo Biloba for Alzheimer’s Disease: From Mixed Dementia Trials to Biomarker-Confirmed Mild Cognitive Impairment—What Have We Learned over Two Decades, and Is There Finally a Bit of Hope?
topicGinkgo Biloba Memory Randomized Trial
claimThe second study confirmed the GBP benefits on mood states and a visually consistent downward trend in reaction times across all four cognitive performance tests at both GBP dosages, suggesting improved processing speed in response to various stimuli.
evidence level2
citationHawkins K (2026)
sourceHealth Benefits of a Standardized <i>Ginkgo biloba</i> Extract Associated With Phosphatidylserine in Alleviating Mental Stress and Cognitive Performance: Results From Two Exploratory Randomized Trials.
topicGinkgo Biloba Memory Randomized Trial
claimMental health is threatened every day by the stressors of life: frenetic work rhythms, stressful conditions can generate anxiety, depression, cognition, and sleep problems.
evidence level2
citationHawkins K (2026)
sourceHealth Benefits of a Standardized <i>Ginkgo biloba</i> Extract Associated With Phosphatidylserine in Alleviating Mental Stress and Cognitive Performance: Results From Two Exploratory Randomized Trials.
topicGinkgo Biloba Memory Randomized Trial
claimAmong natural products with properties to support mental health, Gingko biloba extract with phosphatidylserine (GBP) was exploited with the aim of evaluating its benefits in cognitive function, mood regulation, and overall quality of life.
evidence level2
citationHawkins K (2026)
sourceHealth Benefits of a Standardized <i>Ginkgo biloba</i> Extract Associated With Phosphatidylserine in Alleviating Mental Stress and Cognitive Performance: Results From Two Exploratory Randomized Trials.
topicGinkgo Biloba Memory Randomized Trial
claimIn addition, an overview of systematic reviews synthesized the broader EGb 761 evidence base across indications and highlighted that conclusions require caution given the methodological limitations of many reviews [].
evidence level3
citationYang YoungSoon (2026)
sourceGinkgo Biloba for Alzheimer’s Disease: From Mixed Dementia Trials to Biomarker-Confirmed Mild Cognitive Impairment—What Have We Learned over Two Decades, and Is There Finally a Bit of Hope?
topicGinkgo Biloba Memory Randomized Trial
claimReal-world observational analyses have also reported associations between prescriptions of Ginkgo leaf extract and reduced risk of dementia severity progression, albeit with the inherent limitations of non-randomized designs [].
evidence level3
citationYang YoungSoon (2026)
sourceGinkgo Biloba for Alzheimer’s Disease: From Mixed Dementia Trials to Biomarker-Confirmed Mild Cognitive Impairment—What Have We Learned over Two Decades, and Is There Finally a Bit of Hope?
topicGinkgo Biloba Memory Randomized Trial
claimAccordingly, this review revisits the historical evidence base with explicit attention to heterogeneity and methodological design, and then examines biomarker-confirmed AD-spectrum studies as a potential pivot point.
evidence level3
citationYang YoungSoon (2026)
sourceGinkgo Biloba for Alzheimer’s Disease: From Mixed Dementia Trials to Biomarker-Confirmed Mild Cognitive Impairment—What Have We Learned over Two Decades, and Is There Finally a Bit of Hope?
topicGinkgo Biloba Memory Randomized Trial
claim1 2 Alzheimer’s disease (AD) remains the most common cause of dementia and continues to impose a major burden on patients, caregivers, and healthcare systems [].
evidence level3
citationYang YoungSoon (2026)
sourceGinkgo Biloba for Alzheimer’s Disease: From Mixed Dementia Trials to Biomarker-Confirmed Mild Cognitive Impairment—What Have We Learned over Two Decades, and Is There Finally a Bit of Hope?

Source documents

  1. Health Benefits of a Standardized <i>Ginkgo biloba</i> Extract Associated With Phosphatidylserine in Alleviating Mental Stress and Cognitive Performance: Results From Two Exploratory Randomized Trials.
  2. Ginkgo Biloba for Alzheimer’s Disease: From Mixed Dementia Trials to Biomarker-Confirmed Mild Cognitive Impairment—What Have We Learned over Two Decades, and Is There Finally a Bit of Hope?